Dr Peter Fellner

Executive Chairman of Vernalis plc

Dr Peter Fellner, 64, has been a Member of the Supervisory Board of Evotec AG since June 2005. He was appointed as Chairman of Vernalis plc in January 2003 and as Executive Chairman in April 2003. Previously, he was Chairman of Celltech Group plc, having served as its Chief Executive Officer from 1990 to 2003. He oversaw its development into the UK's largest biotechnology company, until its acquisition by UCB in 2004. Before joining Celltech, Dr Fellner served as Chief Executive Officer of Roche UK, from 1986 to 1990. From 1984 to 1986 he was Director of the Roche UK Research Center.

Dr Fellner is also Chairman of Acambis plc and Astex Therapeutics Ltd, and a Non-executive Director of UCB S.A., QinetiQ Group plc, Bespak plc and Isis Innovation Ltd. In addition, he is a Member of the UK Medical Research Council and a Member of the Apax Healthcare Advisory Board.